The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events is a research paper published in Cancer Letters (2022). On theSindex it has a DataRank of 0.546. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.546
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA179120
NCI NIH HHS
Grant: P30 CA054174
NCI NIH HHS
Grant: T32 CA148724
NCI NIH HHS
Grant: R01 CA239227
NCATS NIH HHS
Grant: UL1 TR001120
FWCI
2.79
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals